SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $225,000 | -93.7% | 3 | -93.5% | 0.00% | -100.0% |
| Q1 2022 | $3,593,000 | -31.2% | 46 | -20.7% | 0.00% | 0.0% |
| Q4 2021 | $5,223,000 | -87.4% | 58 | -87.1% | 0.00% | -90.0% |
| Q3 2021 | $41,615,000 | +10.2% | 450 | -17.4% | 0.01% | +11.1% |
| Q2 2021 | $37,757,000 | -7.0% | 545 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $40,617,000 | -62.5% | 545 | -14.3% | 0.01% | -62.5% |
| Q4 2020 | $108,427,000 | +21.4% | 636 | 0.0% | 0.03% | +23.1% |
| Q3 2020 | $89,309,000 | -12.4% | 636 | 0.0% | 0.03% | -3.7% |
| Q2 2020 | $101,969,000 | +63.9% | 636 | 0.0% | 0.03% | +58.8% |
| Q1 2020 | $62,211,000 | -76.4% | 636 | -68.6% | 0.02% | -65.3% |
| Q4 2019 | $263,390,000 | +72.9% | 2,023 | 0.0% | 0.05% | +81.5% |
| Q3 2019 | $152,343,000 | -50.4% | 2,023 | 0.0% | 0.03% | -50.0% |
| Q2 2019 | $307,277,000 | +27.5% | 2,023 | 0.0% | 0.05% | +12.5% |
| Q1 2019 | $241,028,000 | +27.1% | 2,023 | +16.4% | 0.05% | +41.2% |
| Q4 2018 | $189,609,000 | -16.1% | 1,738 | +24.1% | 0.03% | -19.0% |
| Q3 2018 | $226,029,000 | +22.2% | 1,400 | 0.0% | 0.04% | +35.5% |
| Q2 2018 | $184,974,000 | – | 1,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |